Edward Miller
General Counsel bei ALLOVIR, INC.
Vermögen: 407 772 $ am 30.04.2024
Aktive Positionen von Edward Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLOVIR, INC. | General Counsel | 01.01.2019 | - |
Unternehmenssekretär | 01.01.2019 | - |
Karriereverlauf von Edward Miller
Ehemalige bekannte Positionen von Edward Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Compliance Officer | 17.09.2014 | 01.05.2017 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | General Counsel | 01.01.2000 | 01.01.2014 |
ELOXX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - | - |
Finanzdirektor/CFO | - | - |
Ausbildung von Edward Miller
Princeton University | Undergraduate Degree |
Rutgers Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
General Counsel | 2 |
Compliance Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALLOVIR, INC. | Health Technology |
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Börse
- Insiders
- Edward Miller
- Erfahrung